After finishing at $26.72 in the prior trading day, Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed at $25.70, down -3.82%. In other words, the price has decreased by -$1.02 from its previous closing price. On the day, 744148 shares were traded. RCKT stock price reached its highest trading level at $26.20 during the session, while it also had its lowest trading level at $25.30.
Ratios:
Our goal is to gain a better understanding of RCKT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.80 and its Current Ratio is at 7.80. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on April 02, 2024, initiated with a Neutral rating and assigned the stock a target price of $39.
On October 24, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $65.
On February 01, 2023, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $45.Morgan Stanley initiated its Overweight rating on February 01, 2023, with a $45 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 21 ’24 when Makker Gotham sold 274,000 shares for $28.43 per share. The transaction valued at 7,790,943 led to the insider holds 365,912 shares of the business.
Militello John sold 2,490 shares of RCKT for $69,979 on Mar 21 ’24. The insider now owns 55,239 shares after completing the transaction at $28.10 per share. On Feb 29 ’24, another insider, Militello John, who serves as the insider of the company, sold 10,000 shares for $29.84 each. As a result, the insider received 298,450 and left with 21,517 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 2.33B and an Enterprise Value of 1.98B.
Stock Price History:
Over the past 52 weeks, RCKT has reached a high of $32.53, while it has fallen to a 52-week low of $14.89. The 50-Day Moving Average of the stock is 28.34, while the 200-Day Moving Average is calculated to be 22.92.
Shares Statistics:
The stock has traded on average 727.64K shares per day over the past 3-months and 543.31k shares per day over the last 10 days, according to various share statistics. A total of 90.28M shares are outstanding, with a floating share count of 84.11M. Insiders hold about 7.07% of the company’s shares, while institutions hold 96.05% stake in the company. Shares short for RCKT as of Mar 15, 2024 were 10.24M with a Short Ratio of 14.08, compared to 9.2M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.32% and a Short% of Float of 14.74%.
Earnings Estimates
Its stock is currently analyzed by 11 different market analysts. On average, analysts expect EPS of -$0.68 for the current quarter, with a high estimate of -$0.5 and a low estimate of -$0.83, while EPS last year was -$0.73. The consensus estimate for the next quarter is -$0.71, with high estimates of -$0.49 and low estimates of -$0.85.
Analysts are recommending an EPS of between -$1.95 and -$3.38 for the fiscal current year, implying an average EPS of -$2.75. EPS for the following year is -$1.88, with 12 analysts recommending between -$0.1 and -$3.17.
Revenue Estimates
Based on 10 analysts’ estimates, the company’s revenue will be $167.81M in the next fiscal year. The high estimate is $325.82M and the low estimate is $23.1M. The average revenue growth estimate for next year is up 751.80% from the average revenue estimate for this year.
